Dimiter Stanchev Dimitrov

This inventor holds 102 USPTO granted patents and 32 published patent applications, plus 5 CIPO patents and 34 EPO patents, primarily in Cancer Immunotherapy (CPC class C07K2317-21). Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Lentigen Technology, Inc., Biomed Valley Discoveries, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dimiter Stanchev Dimitrov. Retrieved from https://idiyas.com/inventor/dimiter-stanchev-dimitrov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 102 (Patent Applications = 32)

% Patents Active = 88.2

CIPO Patents = 5 (Patent Applications = 10)

EPO Patents = 34 (Patent Applications = 56)

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 243(Granted Patents)

Forward Citations (Not Self Cited) = 203(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Rockville, MD (US) (2007 - 2014)
Frederick, MD (US) (2008 - 2024)
Pittsburgh, PA (US) (2020 - 2024)

Company Filing History:

92 out of 3,697

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

17 out of 40

Lentigen Technology, Inc.

patents

15 out of 43

Biomed Valley Discoveries, Inc.

patents

4. 6 out of 621

Memorial Sloan Kettering Cancer Center

patents

5. 3 out of 2,785

Purdue Research Foundation

patents

6. 3 out of 196

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

7. 2 out of 1,208

Scripps Research Institute

patents

8. 2 out of 301

The Children's Hospital of Philadelphia

patents

9. 2 out of 657

The Hong Kong University of Science and Technology

patents

10. 2 out of 1,962

University of Pittsburgh

The United States of America as Represented by the Department of Health

patents

13. 1 out of 11

Tri-Institutional Therapeutics Discovery Institute

patents

14. 1 out of 8,753

US Government as Represented by the Secretary of the Army

16. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Anti-ROR1

Monoclonal Antibodies

CD22 Immunotherapy

CD19 Immunotherapy

FGFR4

Chimeric Antigen Receptors

CD38

Tumor-Associated Stroma

Glypican-2

CD123

Tumor Cells

Cancer Treatments

102 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12714750 - Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy (2026-08-25),

2. 12703760 - MOLECULES THAT BIND TO CD66e POLYPEPTIDES (2026-08-11),

3. 12630646 - CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 (2026-05-19),

4. 12624104 - Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy (2026-05-12),

5. 12540179 - Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy (2026-02-03),

6. 12453780 - Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use (2025-10-28),

7. 12391958 - Compositions and methods for treating cancer with anti-CD38 immunotherapy (2025-08-19),

8. 12378321 - ADAM17 binding molecules and uses thereof (2025-08-05),

9. 12037404 - Human monoclonal antibodies against EphA4 and their use (2024-07-16),

10. 12037403 - Compositions and methods for treating cancer with anti-CD123 immunotherapy (2024-07-16),

11. 12018077 - Methods of treatments using antigen-binding proteins targeting CD56 (2024-06-25),

12. 12012455 - Human monoclonal antibodies specific for FLT3 and uses thereof (2024-06-18),

13. 11970528 - Compositions and methods for treating cancer with anti-mesothelin immunotherapy (2024-04-30),

14. 11939377 - Affinity matured CD22-specific monoclonal antibody and uses thereof (2024-03-26),

15. 11878052 - Compositions and methods for treating cancer with anti-CD22 immunotherapy (2024-01-23),

Title: The Innovative Journey of Dimiter Stanchev Dimitrov

Introduction:

Dimiter Stanchev Dimitrov is a visionary inventor based in Frederick, MD (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Dimiter Stanchev Dimitrov holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights:

With over two decades of experience in research and development, Dimiter Stanchev Dimitrov has worked for leading tech companies, where he spearheaded projects that have revolutionized industries and improved people's lives.

Collaborations:

Throughout his career, Dimiter Stanchev Dimitrov has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion:

Dimiter Stanchev Dimitrov's relentless pursuit of innovation and his passion for creating solutions to complex challenges make him a true pioneer in the world of technology, inspiring the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.